Obalon Therapeutics, Inc. announced that in connection with recent leadership changes at the Company, on June 29, 2020, the Company's Board of Directors appointed Kim Kamdar, an independent director, as Chairperson of the Board of Directors. Ms. Kamdar assumes the role previously held by Andrew Rasdal, who was recently appointed President and Chief Executive Officer of the Company. Mr. Rasdal will continue to serve as a director of the Company.